Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
Int J Mol Sci. 2022 Mar 8;23(6):2919. doi: 10.3390/ijms23062919.
Int J Mol Sci. 2022.
PMID: 35328342
Free PMC article.
Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma.
Fujibayashi Y, Isa R, Nishiyama D, Sakamoto-Inada N, Kawasumi N, Yamaguchi J, Kuwahara-Ota S, Matsumura-Kimoto Y, Tsukamoto T, Chinen Y, Shimura Y, Kobayashi T, Horiike S, Taniwaki M, Handa H, Kuroda J.
Fujibayashi Y, et al.
Cancers (Basel). 2020 Aug 6;12(8):2206. doi: 10.3390/cancers12082206.
Cancers (Basel). 2020.
PMID: 32781708
Free PMC article.
Item in Clipboard
Cite
Cite